Jiang et al. combined mild immunogenic ferroptosis with programmed cell death 1 (PD-1) immune checkpoint blockade therapy to treat cancer, and his team prepared Fe3O4 magnetic NPs loaded with sulfasalazine (SAS) and coated with PLTM (Fe3O4-SAS@PLT). This evidence concerns the gene PDCD1 and cancer.